Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EnteroBiotix logo — Mastering the microbiome, transforming lives®

EnteroBiotix

Mastering the microbiome, transforming lives®

Founded 2017 55 employees Venture round Total: $64.00M Biotechnology, Health Care +1

General Information

Company Name EnteroBiotix
Founded Year 2017
Founders / Decision Makers
Team member
Employees 55
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with EnteroBiotix. To contact EnteroBiotix, visit enterobiotix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About EnteroBiotix

EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to the structure and function of the gut microbiome. Founded in 2017, the company operates in the Biotechnology, Health Care, and Life Sciences industries. They recently secured a significant €27.00M Series B investment on April 4, 2024, with funding from notable investors including Scottish Enterprise, Scottish National Investment Bank, Thairm Bio, and Kineticos Ventures. With their slogan "Mastering the microbiome, transforming lives®," EnteroBiotix is poised to make a meaningful impact in the field of microbiome therapeutics.

Taxonomy: microbiome therapeutics, gut microbiome, disease treatment, infection control, medical innovation, microbiome research, biopharmaceuticals, biological therapies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture round £19.00M 2
Scottish National Investment Bank
Scottish National Investment Bank, Thairm Bio
04 May 2026
Series B €27.00M 4
Scottish Enterprise Scottish National Investment Bank
Scottish Enterprise, Scottish National Investment Bank +2
04 Apr 2024
Series A £15.50M 4
SIS Ventures Scottish Enterprise
SIS Ventures, Scottish Enterprise +2
07 Sep 2021
Seed Round £2.00M 2
SIS Ventures
SIS Ventures, Bank Workers Charity
29 May 2019
Seed Round £500.00K -
22 Jun 2017

Latest News

View All
EnteroBiotix secures £19M to support IBS microbiome clinical trial — Tech
EnteroBiotix secures £19M to support IBS microbiome clinical trial
Tech May 04, 2026

EnteroBiotix Alternatives & Competitors

View All Alternatives
EnteroBiotix vs
PharmaBiome AG
PharmaBiome AG Switzerland

Pioneering the development of microbiome-based therapies using proprietary tools for their design an...

Convertible Note
11 employees
Biotechnology, Health Care
EnteroBiotix vs
MRM Health
MRM Health Belgium

Redefining microbiome-based therapeutics

Grant
45 employees
Biotechnology, Health Care
EnteroBiotix vs
MD NutriAcademy
MD NutriAcademy Turkey

Bioengineering company, using Omics and Systems Bio. applications to examine gut microbiome for heal...

3 employees
Digital Health, Health Care
Also compare with: EnteroBiotix vs MaaT Pharma MaaT Pharma View all alternatives

FAQ About EnteroBiotix

Mastering the microbiome, transforming lives®
EnteroBiotix was founded in 2017.
EnteroBiotix operates in Biotechnology, Health Care and Life Sciences. Its work centres on microbiome therapeutics, gut microbiome, disease treatment and infection control.
EnteroBiotix has approximately 55 employees.
EnteroBiotix has completed 5 funding rounds, raising a total of $64.00M. The latest funding stage is Venture round.
Top alternatives and competitors to EnteroBiotix include PharmaBiome AG, MRM Health, MD NutriAcademy, Nitrase Therapeutics, Ritter Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EnteroBiotix and PharmaBiome AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EnteroBiotix, https://bouncewatch.com/company/enterobiotix, updated 4 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes